JPRN-UMIN000038603已完成未知
The persistence of fesoterodine and the reasons for withdrawal from treatment of treatment-naive female patients with overactive bladder in the real-world clinical setting - Persistence and reasons for withdrawal of fesoterodine
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients with urinary tract infection, large postvoid residual volume, a previous treatment history for OAB, and contraindications to use of fesoterodine
研究者
相似试验
已完成
不适用
rodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladderneurogenic bladderJPRN-UMIN000037584Dokkyo Medical University77
尚未招募
不适用
Objective assessment of fesoterodine for overactive bladder with benign prostatic hyperplasiaOveractive bladder associated with benign prostatic hyperplasiaJPRN-UMIN000010296Dept. of Urology, Kyoto University Graduate School of Medicine40
已完成
3 期
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.Overactive BladderNCT02614482Stéphane Bolduc26
已完成
不适用
Effects of fesoterodine on frequency/volume chart in treatment-naive female patients with overactive bladder in the real-world clinical settingOveractive bladderJPRN-UMIN000040425Hokkaido Prefectural Esashi Hospital100
已完成
4 期
Fesoterodine fumarate for the treatment of neurogenic bladdereurogenic detrusor overactivity (NDO)Nervous System DiseasesNeurogenic detrusor overactivity (NDO)ISRCTN22433402ational Rehabilitation Center85